Mawdsley-Brooks & Co

What Mawdsley-Brooks & Co does

Mawdsley-Brooks & Co. Ltd. ("Mawdsleys") is the UK's largest independent pharmaceutical distributor dedicated to NHS Secondary Care, founded in 1825 and operated across six generations of the founding Mawdsley family with Harry Westall as Chairman (since 2020) and William Sanders as Group CEO. The company operates three integrated service lines: Secondary Care Services (hospital distribution, import of unlicensed medicines, and over-labelling); Pre-Wholesale (3PL under the MPW brand) providing pharmaceutical storage, fulfilment, reporting, and value-added services across MHRA-approved sites; and Pharma/International Services delivering named patient programmes, pharmacovigilance, and global distribution in 134 countries through wholly-owned subsidiaries in Israel (MBI, 2010), Brazil (MBB, 2013), and Belgium (Nadimed, 2023).

The technology platform comprises a proprietary Stream Go Transport Management System (real-time track and trace, sign-on-glass proof of delivery, live temperature monitoring), EDI integration (with documented SAP integration for Daiichi Sankyo enabling full order-to-cash), and customer-facing portals (Mawdsleys Online / E-Awards and 3PL Client Portal) supporting ordering, stock visibility, batch/expiry data, and stock forecasting. Dual temperature-controlled vehicles (ambient 15-25°C and cold-chain 2-8°C) operate in GDP-compliant fashion, with infrastructure including 390,000+ sq ft of MHRA-approved storage, 64,000+ pallet positions, and over-labelling capacity of 250,000+ packs per month.

Revenue is generated through multiple B2B streams: transaction-fee wholesale distribution of licensed and unlicensed pharmaceuticals to NHS hospitals; managed-services 3PL contracts for pharmaceutical manufacturers; professional-services over-labelling with QP release; and managed-services named patient programmes across UK, Brazil, and Israel. The company holds MHRA Wholesale Dealer Authorisations, Active Substance Authorisation, GMP certification, Net Zero certification, and NHS Evergreen Level 2 recognition. In 2018, Mawdsleys divested its community pharmacy wholesale business to DE Group to focus on NHS Secondary Care distribution and bespoke hospital solutions.

Name

Mawdsley-Brooks & Co

Legal name

Mawdsley-Brooks & Co. Ltd.

Website

https://mawdsleys.co.uk

Company type

Private

Founded year

1825

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mawdsley-Brooks & Co. is a UK-based, family-owned pharmaceutical distributor serving NHS Secondary Care hospitals and pharmaceutical manufacturers with hospital distribution, imported unlicensed medicines, GMP over-labelling, and third-party logistics (MPW), operating across the UK, Israel, Brazil, Belgium, and 134 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Trucking & Courier Services (No Air) (4210)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

akta.pro secondary industries

Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmaceutical Distributors (HLAIAJAB), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical distribution services
• Hospital pharmaceutical logistics
• Unlicensed medicines import
• Pharmaceutical 3PL services
• Over-labelling services

Headquarters

HQ city

Salford

HQ country

United Kingdom

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Wholesale Distribution: Distribution of licensed and unlicensed pharmaceutical products to NHS hospitals and healthcare providers. Revenue generated through product distribution with no minimum order levels and daily deliveries.
2. Third-Party Logistics (3PL): Pre-wholesale storage and logistics services for pharmaceutical companies including warehousing, order fulfillment, and distribution. Revenue generated through service fees for storage and logistics management.
3. Over-labelling Services: Regulatory compliant relabelling and repacking services for pharmaceutical products with QP release.
4. Named Patient Programmes: Specialist services for pharma companies to provide pre-license access to medicines in the UK, Brazil, and Israel markets.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Mawdsley-Brooks & Co. (Mawdsleys) is the UK's largest independent pharmaceutical distributor dedicated to NHS Secondary Care, providing wholesale distribution of licensed and unlicensed medicines to hospitals. The company operates three core service lines: Secondary Care Services (hospital distribution, imported unlicensed medicines, over-labelling), Pre-Wholesale 3PL services (storage, logistics, fulfilment, value-added relabelling), and Pharma Services (named patient programmes, regulatory and pharmacovigilance services) for pharmaceutical manufacturers and biotech companies.

Product overview

Mawdsleys is the UK's largest independent pharmaceutical distributor dedicated to NHS Secondary Care. The company operates a platform of interconnected services spanning hospital distribution, imported unlicensed medicines, and over-labelling services under its Secondary Care Services division. Its MPW (Mawdsleys Pre Wholesale) 3PL division provides pharmaceutical storage, logistics and fulfilment, information reporting, order processing, and value-added services including GMP-compliant relabelling. The company operates its own Transport Management System (Stream Go) for real-time tracking and offers customer-facing portals (Mawdsleys Online/E-Awards and 3PL Client Portal) for ordering and account management. Mawdsleys Specialist Pharma division handles named patient programmes, regulatory affairs, and pharmacovigilance services for pharma companies across UK, Brazil, and Israel. The company also provides international distribution services to 134 countries through its global network.

Differentiator

Problem solved

Functional benefit

Brands

• MPW (Mawdsleys Pre Wholesale): Third-party logistics (3PL) division providing pharmaceutical storage and distribution services to the healthcare industry.
• Mawdsleys Specialist Pharma

Products and services

• Hospital Distribution Specialist pharmaceutical distribution service for NHS Secondary Care hospitals. Provides contract and non-contract medicines, daily deliveries with no minimum order, dedicated account managers, EDI and online ordering, and same-day urgent deliveries.
• Imported Unlicensed Medicines

Quantifiable outcome

• 99% of customers say deliveries are reliable and carried out professionally
• +5 more outcomes

Named customers17 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Eleven partnerships are on record, tiered minor and core.

• City Electrical FactorsminorImplementation/ SI/ Consulting Partner · 1 January 2024Partner for EV charging infrastructure delivery at Redhouse distribution centre.
• Russell WBHOminorImplementation/ SI/ Consulting Partner · 1 January 2023Main contractor for the expansion of Doncaster Redhouse facility doubling size to 300,000 sq ft.
• Sol Pv GroupminorImplementation/ SI/ Consulting Partner · 1 January 2023Specialist contractor for installation of 1,688kW PV array with 3,375 solar panels on Doncaster 3PL facility roof.
• WattstorminorImplementation/ SI/ Consulting Partner · 1 January 2023Specialist contractor for battery storage system (2,600kWh) at Doncaster facility.
• Heatworks LtdminorImplementation/ SI/ Consulting Partner · 1 January 2023Partner for environmental improvements and EV charging infrastructure at Doncaster Redhouse facility.
• Beaumont LordminorImplementation/ SI/ Consulting Partner · 1 January 2023Partner in construction project for Doncaster facility expansion.
• Inter CareminorOthers · 1 January 2023Charity providing medical aid to Africa. Mawdsleys partnered with University Hospitals Derby and Burton NHS Foundation Trust to support medical aid shipments to Northern Malawi.
• IntoUniversity Salford CentralcoreStrategic or Co-development Partner · 1 January 2022Mawdsleys is a cornerstone funder of IntoUniversity Salford Central - a partnership between IntoUniversity, University of Salford, and University of Manchester. The centre supports over 1,000 young people aged 7-18 annually.
• Daiichi Sankyo UK LtdcoreChannel Partner/ Reseller/ Distributor · 1 January 2016MPW (Mawdsleys Pre Wholesale) selected as 3PL logistics service provider. Successfully integrated Daiichi Sankyo's SAP IT systems with Mawdsleys' software enabling complete order to cash service.
• International Health Partners (IHP)coreStrategic or Co-development Partner · 1 January 2004IHP launched as an NGO focusing on healthcare in 2004. Mawdsleys works closely with IHP supporting their vital work including maternal health appeals and donating quality long-dated medicines.
• Healthcare Distribution Association (HDA) UKcoreOthersMember of HDA UK, the trade association representing pharmaceutical wholesalers and distributors in the UK.

Scale indicators20 records

Recent moves15 records

Expansion highlights7 records

Direct peers

• Alliance Healthcare: UK pharmaceutical wholesaler and distributor serving pharmacies, hospitals, and manufacturers; directly comparable to Mawdsleys in hospital-channel distribution and offers competing 3PL and wholesale services across the UK.
• Nadimed: Belgian pharmaceutical distributor acquired by Mawdsleys in 2023; a directly comparable specialty pharma distributor operating in continental Europe and now part of Mawdsleys' group.
• Durbin PLC: UK-based specialist pharmaceutical distributor supplying unlicensed, orphan, and comparator medicines globally; a direct peer to Mawdsleys in imported unlicensed medicines and named-patient supply.
• DE Group (DE Pharma): European pharmaceutical distribution group that absorbed Mawdsleys' community pharmacy wholesale in 2018; directly comparable in pharma distribution and a current commercial counterparty for some NHS customers.
• Clinigen Group: Global pharmaceutical services company with comparators, unlicensed medicines, and clinical trial supply services; directly comparable to Mawdsleys' Specialist Pharma division in named patient and unlicensed medicine access.

Emerging players

• Biomapas: Pharmaceutical services company offering distribution, regulatory, and pharmacovigilance across Central and Eastern Europe; overlaps with Mawdsleys Specialist Pharma division's named patient and regulatory service offering.
• Specialised Therapeutics (ST Pharma): Specialty pharma distributor focused on hospital-channel and unlicensed/specialty medicines in European and emerging markets; comparable to Mawdsleys' imported unlicensed medicines and Named Patient Programmes.

Broad incumbents

• Phoenix Group: Pan-European pharmaceutical wholesale, distribution, and pharmacy group with UK wholesale operations; broader portfolio than Mawdsleys but a direct competitor in pharma distribution and 3PL.
• Walgreens Boots Alliance (Alliance Healthcare UK): Global healthcare and pharmacy group whose Alliance Healthcare UK business competes in pharmaceutical distribution, hospital supply, and pre-wholesale services.

Regional players

• Biopartners (Biopartners GmbH): European specialty biopharmaceutical distributor with focus on specialty and unlicensed medicines in DACH/Central Europe; comparable business model to Mawdsleys in specialty pharma distribution outside the UK.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat8 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/mawdsleys
• LinkedInlinkedin.com/company/mawdsleys
• Instagraminstagram.com/mawdsleys

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mawdsley-Brooks & Co